St. Jude Children's Research Hospital, UTHSC assisting in local site.
Author: Brad Broders
Updated: 6:09 PM CST December 11, 2020
MEMPHIS, Tenn — As several COVID-19 vaccines inch closer to federal approval and mass distribution in the coming weeks, in the Mid-South Friday, local participants did their part in another vaccine trial now underway.
St. Jude and the University of Tennessee Health Science Center recently opened a site for Johnson & Johnson's Phase 3 trail of its COVID-19 vaccine candidate.
For one participant, it served a purpose beyond himself.
"At some point we've got to figure out what's best for the whole and not just individuals," Tony Milton, a vaccine participant, said.